Thiruvanantha Puram Today

Necrotizing Enterocolitis Market: Industry Analysis, Drugs, Pipeline, Treatment and Key Companies by DelveInsight

 Breaking News
  • No posts were found

Necrotizing Enterocolitis Market: Industry Analysis, Drugs, Pipeline, Treatment and Key Companies by DelveInsight

October 13
01:28 2021
Necrotizing Enterocolitis Market: Industry Analysis, Drugs, Pipeline, Treatment and Key Companies by DelveInsight
Necrotizing Enterocolitis Market

Necrotizing Enterocolitis (NEC) is an inflammatory disease of intestine largely occurring in preterm infants with a wide range of damage from minimal injury limited to mucosa to extensive necrosis of bowel wall and perforation. It is the most common neonatal gastrointestinal emergency, particularly in those born at, 32 weeks’ gestation and/or, 1,500 g birth weight. The exact cause of NEC isn’t known. However, it’s believed that a lack of oxygen during a difficult delivery may be a contributing factor. When there’s reduced oxygen or blood flow to the intestine, it can become weak. A weakened state makes it easier for bacteria from the food entering the intestine to cause damage to the intestinal tissues. This can lead to the development of an infection or NEC.

 

DelveInsight’s Necrotizing Enterocolitis Market Insights, Epidemiology, and Market Forecast-2030″ report delivers an in-depth understanding of the Necrotizing Enterocolitis, historical and forecasted epidemiology as well as the Necrotizing Enterocolitis market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.

 

Some facts of Necrotizing Enterocolitis Market Report are:

  • As per Robert C. Holman et al, NEC occurs in approximately 10% of VLBW infants and is associated with 1.0–7.5% of all neonatal intensive care unit admissions. Also, found that approximately 4500 neonates (or approximately 1 infant per 1000 live births) are hospitalized each year in the United States
  • According to Simon Eaton UK NEC study, estimates based on over 100,000 infants, of whom more than 500 had severe NEC, with an incidence of around 3% in infants
  • According to Clare M. Rees et Al, Bell’s stage I was the most frequent maximum stage of NEC diagnosed with 45%, stage II at 18% to 24% and stage III at 30% to 37% in the United Kingdom
  • According to Katherine E. Gregory et al, the majority of NEC cases are treated medically, and more than one-fourth of infants will require urgent surgical intervention including exploratory laparotomy, bowel resection, and ostomy

 

Request for Sample Report: https://www.delveinsight.com/sample-request/necrotizing-enterocolitis-market

 

Scope of Necrotizing Enterocolitis Market Report are:

  • The report covers the descriptive overview of Necrotizing Enterocolitis, explaining its causes, signs and symptoms, pathophysiology, diagnosis and currently available therapies
  • Comprehensive insight has been provided into the Necrotizing Enterocolitis epidemiology and treatment in the 7MM
  • Additionally, an all-inclusive account of both the current and emerging therapies for Necrotizing Enterocolitis are provided, along with the assessment of new therapies, which will have an impact on the current treatment landscape
  • A detailed review of Necrotizing Enterocolitis market; historical and forecasted is included in the report, covering drug outreach in the 7MM
  • The report provides an edge while developing business strategies, by understanding trends shaping and driving the global Necrotizing Enterocolitis market

 

Request for Sample Report: https://www.delveinsight.com/sample-request/necrotizing-enterocolitis-market

 

Some of Necrotizing Enterocolitis Companies are:

  • Infant Bacterial Therapeutics
  • Leadiant Biosciences
  • Noveome Biotherapeutics
  • Prometic Life Sciences
  • And Many Others

 

Necrotizing Enterocolitis Therapies are:

  • IBP-9414
  • STP206
  • Inter-Alpha-Inhibitor-Proteins 
  • And Many Others

 

View Report: https://www.delveinsight.com/report-store/necrotizing-enterocolitis-market

 

Table of Contents:

1. Key Insights

2. Executive Summary of Necrotizing Enterocolitis

3. Competitive Intelligence Analysis for Necrotizing Enterocolitis

4. Necrotizing Enterocolitis: Market Overview at a Glance

4.1. Necrotizing Enterocolitis Total Market Share (%) Distribution in 2018

4.2. Necrotizing Enterocolitis Total Market Share (%) Distribution in 2030

5. Necrotizing Enterocolitis: Disease Background and Overview

6. Patient Journey

7. Necrotizing Enterocolitis Epidemiology and Patient Population

8. Treatment Algorithm, Current Treatment, and Medical Practices

8.1. Necrotizing Enterocolitis Treatment and Management

8.2. Necrotizing Enterocolitis Treatment Algorithm

9. Unmet Needs

10. Key Endpoints of Necrotizing Enterocolitis Treatment

11. Marketed Products

List to be continued in report

12. Emerging Therapies

List to be continued in report

13. Necrotizing Enterocolitis: Seven Major Market Analysis

14. Attribute analysis

15. 7MM: Market Outlook

16. Access and Reimbursement Overview of Necrotizing Enterocolitis

17. KOL Views

18. Market Drivers

19. Market Barriers

20. Appendix

21. DelveInsight Capabilities

22. Disclaimer

 

About Delveinsight: 

DelveInsight Business Research is a leading Market Research, and Business Consultant focused purely on Healthcare. It helps pharma companies by providing them with end-to-end services to solve their business problems.

Get hold of all the Pharma and healthcare market research reports on our market research subscription-based platform PharmDelve.

Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Ankit Nigam
Email: Send Email
Phone: +19193216187
Address:304 S. Jones Blvd #2432
City: Albany
State: New York
Country: United States
Website: https://www.delveinsight.com/report-store/necrotizing-enterocolitis-market

Related Articles